Cargando…
An effective treatment in Erdheim Chester disease: vemurafenib: a case report
BACKGROUND: Erdheim Chester disease (ECD) is a rare disease with multisystemic involvement in the group of non-langerhans cell histiocytosis. Although nearly 100 years have passed since its definition, the number of cases reported all over the world is below 1000. In addition to the rarity of the di...
Autores principales: | Bozan, Ersin, Darçın, Tahir, Yaman, Samet, Yiğenoğlu, Tuğçe Nur, Kızıl Çakar, Merih, Dal, Mehmet Sinan, Altuntaş, Fevzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568759/ https://www.ncbi.nlm.nih.gov/pubmed/37821987 http://dx.doi.org/10.1186/s13256-023-04153-z |
Ejemplares similares
-
Molecular evaluation of mutations in acute myeloid leukemia patients from Turkey: A single-center study
por: Merdin, Alparslan, et al.
Publicado: (2021) -
Analysis of pre-chemotherapy WBC, PLT, monocyte, hemoglobin, and MPV levels in acute myeloid leukemia patients with WT1, FLT3, or NPM gene mutations
por: Merdin, Alparslan, et al.
Publicado: (2020) -
Gemcitabine, dexamethasone and cisplatin (GDP) is an effective and well-tolerated mobilization regimen for relapsed and refractory lymphoma: a single center experience
por: BATGİ, Hikmettullah, et al.
Publicado: (2021) -
Orbital and chorioretinal manifestations of Erdheim-Chester disease treated with vemurafenib
por: Huang, Laura C., et al.
Publicado: (2018) -
Vemurafenib in the Treatment of Erdheim Chester Disease: A Systematic Review
por: Aziz, Syed N, et al.
Publicado: (2022)